Aminocaproic acid
USP/1021000 - United States Pharmacopeia (USP) Reference Standard
Synonym: 6-Aminocaproic acid; ε-Aminocaproic acid; 6-Aminohexanoic acid; EACA
CAS Number: 60-32-2
Empirical Formula (Hill Notation): C6H13NO2
Molecular Weight: 131.17
MDL Number: MFCD00008238
Linear Formula: H2N(CH2)5CO2H
Product Type: Chemical
| application(s) | pharmaceutical (small molecule) |
| density | 1.042 g/cm3 |
| form | fine crystals |
| powder | |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C6H13NO2/c7-5-3-1-2-4- |
| InChI key | SLXKOJJOQWFEFD-UHFFFAOYSA |
| manufacturer/tradename | USP |
| mp | 207-209 °C (dec.) (lit.) |
| SMILES string | NCCCCCC(O)=O |
| storage temp. | 2-8°C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Biochem/physiol Actions: | Lysine analog. Promotes rapid dissociation of plasmin, thereby inhibiting the activation of plasminogen and subsequent fibrinolysis. Reported to inhibit plasminogen binding to activated platelets. An early report indicated that it inhibits the activation of the first component of the complement system. Binds and inactivates Carboxypeptidase B. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia   . |
| Other Notes: | Sales restrictions may apply. |
| Other Notes: | USP issued SDS can be found here . |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 207-209 °C (dec.) (lit.) |
| Density | 1.042 g/cm3 |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |